FDA Approves Groundbreaking Gene Therapy for Inherited Hearing Loss

In a landmark decision, the U.S. Food and Drug Administration has approved the first-ever gene therapy for genetic hearing loss. The treatment represents a major breakthrough in genetic medicine and offers new hope for individuals with hereditary hearing impairments. By targeting the underlying genetic cause, this personalized approach marks a significant milestone in the field of precision medicine. The approval paves the way for future gene therapies aimed at other inherited conditions.